Related Articles
Purulent bullous epidermal necrolysis: A potential new clinical pattern of drug eruption
Toxic epidermal necrolysis after injection of sclerosing agent and medical adhesive into oesophageal variceal ligation in a patient with a malignant liver tumour: A case report
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis
Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin